These proangiogenic factors promote an immunosuppressed TME by preventing the recruitment of CD8+ T-cells and dendritic cells (DCs), allowing the influx of Treg cells and increasing the expression of PD-1 and PD-L1 on the surface of immune and tumor cells [7,8,21]. Here, CD274 is linked to neoplasm.